1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
| {
| "batch_id": "BATCH-STOCK-VALUATION-QINGFENGPU-TIMELINE-20260825-001",
| "ticker": "600664.SH",
| "company": "哈药股份",
| "as_of": "2026-08-25",
| "v2_status": "BLOCKED",
| "v2_failure": {
| "complete": false,
| "error": "SourceContractError: 网络请求失败：Remote end closed connection without response",
| "error_code": "E_CORE_INPUT",
| "error_type": "CoreInputError",
| "recorded_at": "2026-08-25T19:57:12.790+08:00",
| "rollback_errors": [],
| "run_id": "9a58fc443add4d3cb6f1eeac2c4a1a8c",
| "schema_version": 2,
| "status": "BLOCKED"
| },
| "v2_runtime_package": "v2_600664_SH.failed-9a58fc443add4d3cb6f1eeac2c4a1a8c",
| "v2_raw_artifact_hashes": [
| "103e16a70a4fcc930ece02fd1afca496518e551650d71410388e1613aa6984bc",
| "257cc5467ad6220360a045ed5175fbbf24faef2a9ba91937c4aca317a42125ff",
| "30c1c65513c37ea65ee6e83a7416f801a3863880ee1da0460a163b6b0e5bc39e",
| "731634904a1b4568ba245e2c66c96e5bba7e0439b17ac3e8d99d98aae724b2ff",
| "a02b976e06f4e4d6d4e1526a3085c830769a17fea2bbd665d08170014a1d11c0",
| "b6245b41134b33af72bbd15d71c23734fa469b59df987ccaf8a91c283b285beb",
| "c5b4414b450b397514f9d1ca1278966de6ed56fdc9d79e45bbe81f97dd3d3185",
| "c5bec0b42a57433f83f3a9df28b80f066ab966c64eea7569d88a6baca7d90430"
| ],
| "market_contract": {
| "table": "trading_xuntou.cn_stock_kline_1d_front",
| "source": "xtquant",
| "source_batch_id": "FKL_20260825_161021_6bd1f63d_1d_20260825_00012",
| "updated_at": "2026-08-25 16:38:32",
| "trade_date": "2026-08-25"
| },
| "quote_raw_hash": "",
| "share_proof": {
| "shares": 2518509876.0,
| "shares_fallback": true,
| "shares_fallback_source": "statutory_report:report_shares",
| "report_shares": 2518509876.0,
| "share_unit_correction": null,
| "static_total_shares": 2518509876.0,
| "match_report": true,
| "quote_market_cap": null,
| "price_times_shares": 20676966081.960003,
| "gap_rate": 0.0
| },
| "industry_membership": {
| "industries": [
| "医药"
| ],
| "layers": [
| "reverse:医药、创新药与疫苗",
| "timeline"
| ],
| "research_name": "哈药股份"
| },
| "bounded_gaps": [
| "V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
| "机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
| ],
| "checks": {
| "v1_qa": {
| "error_count": 0,
| "info_count": 0,
| "issues": [],
| "status": "PASS",
| "warning_count": 0
| },
| "label": "偏贵",
| "base_low": 2.5272000000000006,
| "base_high": 6.75,
| "optimistic_high": 13.041,
| "price": 8.21,
| "bubble_status": "泡沫-中"
| }
| }
|
|
